OBJECTIVE: This study investigated the presence of sub-clinical cognitive dysfunction in patients with clinically isolated syndrome (CIS) and the abnormalities of cognitive event-related potentials (ERPs). METHODS: Subclinical cognitive dysfunction was assessed in 20 patients with CIS and in 20 healthy controls. RESULTS: Patients had impairments in verbal learning and long-term memory, evaluating attention, executive function and visuospatial skills, in decreasing order of frequency. SDLT and SIT were the most, and COWAT and BNT were the least affected tests. The N200 and P200 latencies were prolonged, and N100, N200 and P200 amplitudes were reduced in the patients relative to the controls, from the Fz, Cz and Pz electrode positions (p<0.05). CONCLUSION: Detailed cognitive testing is valuable in determining subclinical cognitive dysfunction in CIS patients. ERP abnormalities as well as abnormalities in detailed cognitivetesting in patients with CIS are helpful in the diagnosis of sub-clinical cognitive dysfunction.
OBJECTIVE: This study investigated the presence of sub-clinical cognitive dysfunction in patients with clinically isolated syndrome (CIS) and the abnormalities of cognitive event-related potentials (ERPs). METHODS: Subclinical cognitive dysfunction was assessed in 20 patients with CIS and in 20 healthy controls. RESULTS:Patients had impairments in verbal learning and long-term memory, evaluating attention, executive function and visuospatial skills, in decreasing order of frequency. SDLT and SIT were the most, and COWAT and BNT were the least affected tests. The N200 and P200 latencies were prolonged, and N100, N200 and P200 amplitudes were reduced in the patients relative to the controls, from the Fz, Cz and Pz electrode positions (p<0.05). CONCLUSION: Detailed cognitive testing is valuable in determining subclinical cognitive dysfunction in CIS patients. ERP abnormalities as well as abnormalities in detailed cognitivetesting in patients with CIS are helpful in the diagnosis of sub-clinical cognitive dysfunction.
Authors: L G Grammaldo; T Giampà; P P Quarato; A Picardi; A Mascia; A Sparano; G N Meldolesi; F Sebastiano; V Esposito; G Di Gennaro Journal: Eur J Neurol Date: 2006-04 Impact factor: 6.089
Authors: M P Amato; E Portaccio; B Goretti; V Zipoli; L Ricchiuti; M F De Caro; F Patti; R Vecchio; S Sorbi; M Trojano Journal: Mult Scler Date: 2006-12 Impact factor: 6.312
Authors: R Zivadinov; J Sepcic; D Nasuelli; R De Masi; L M Bragadin; M A Tommasi; S Zambito-Marsala; R Moretti; A Bratina; M Ukmar; R S Pozzi-Mucelli; A Grop; G Cazzato; M Zorzon Journal: J Neurol Neurosurg Psychiatry Date: 2001-06 Impact factor: 10.154
Authors: B S Giesser; M M Schroeder; N G LaRocca; D Kurtzberg; W Ritter; H G Vaughan; L C Scheinberg Journal: Electroencephalogr Clin Neurophysiol Date: 1992-05
Authors: Catherine M Dalton; Declan T Chard; Gerard R Davies; Katherine A Miszkiel; Dan R Altmann; Kryshani Fernando; Gordon T Plant; Alan J Thompson; David H Miller Journal: Brain Date: 2004-03-03 Impact factor: 13.501
Authors: W I McDonald; A Compston; G Edan; D Goodkin; H P Hartung; F D Lublin; H F McFarland; D W Paty; C H Polman; S C Reingold; M Sandberg-Wollheim; W Sibley; A Thompson; S van den Noort; B Y Weinshenker; J S Wolinsky Journal: Ann Neurol Date: 2001-07 Impact factor: 10.422
Authors: Javier J Gonzalez-Rosa; Manuel Vazquez-Marrufo; Encarnacion Vaquero; Pablo Duque; Monica Borges; Carlos M Gomez-Gonzalez; Guillermo Izquierdo Journal: BMC Neurol Date: 2011-06-02 Impact factor: 2.474